Tad and Dianne Taube commit $6 million for pediatric cancer research
Philanthropists TAD and DIANNE TAUBE have committed $6 million to the School of Medicine to establish the Taube Initiative in Pediatric Cancer Research, which will further the development of innovative therapies to improve the cure rates for childhood cancer.
The gift will accelerate the work of researchers at the School of Medicine and Lucile Packard Children’s Hospital Stanford who are exploring promising areas of discovery, such as cancer genomics and immunotherapy. It will support two faculty members performing cutting-edge cancer research in key areas and establish a fund for future innovation.
The Taube Distinguished Scholar in Pediatric Immunotherapy will focus on developing and advancing immunotherapy treatments for childhood cancers. This type of therapy is associated with fewer long-term toxicities than chemotherapy and radiation, which kill cancer cells but also destroy healthy cells and weaken the immune system. Immunotherapy equips the patient’s own immune cells to specifically attack cancer cells.
The Taube Distinguished Scholar for Pediatric Oncology will focus on developing customized therapies to treat childhood cancers utilizing knowledge of the genetic differences found in cancer cells.
In addition, the initiative will support the Taube Innovation Fund in Pediatric Cancer, which will back innovative research and clinical projects within the Division of Hematology/Oncology in the Department of Pediatrics at the School of Medicine.
The Taubes have given to other areas of the School of Medicine and Packard Children’s. Their recent gifts, totaling over $40 million, include:
- $20 million to help open the Tad and Dianne Taube Pavilion at Packard Children’s new main building
- $9.5 million to establish the Tad and Dianne Taube Youth Addiction Initiative
- $5 million to create the Taube Stanford Concussion Collaborative, which advances education, care and research to protect children from concussions
- $3 million to support a collaboration between the School of Medicine and the Gladstone Institutes focused on research related to Huntington’s disease
- $1.4 million for the Taube Pediatric Neurodegenerative Disease Research Fund
- $1 million to support transdisciplinary research through the Stanford Maternal & Child Health Research Institute